Inamed Pays $17.2M To Settle Patent Dispute With Ethicon
As part of the agreement, Inamed will pay royalties to Ethicon on future U.S. sales of the Lap-Band System, initially at 7.5%. Prior to the settlement, Inamed had been accruing a royalty on U.S. sales at 1.2%.
The 7.5% royalty will be reduced to 5.5% if Ethicon is able to obtain approval from...
To view the full article, register now.